Clinical Trial Update: The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD. [NA]

View source ↗

Summary

Clinical trial update documenting an ongoing study on how adherence to hydroxyurea relates to health-related quality of life and barriers in sickle cell disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Beta-plus Thalassemia
• Sickle Beta-thalassemia
• Sickle Beta-zero Thalassemia
• Sickle Cell Disease
• Sickle Cell Disease with Hemoglobin

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Sickle Cell Disease, Sickle B+ Thalassemia | NA | Status: ACTIVE_NOT_RECRUITING